Gynesonics Pulls In $43M

What does Gynesonics do?

Gynesonics, is a women’s healthcare company which is focused on developing minimally invasive solutions for symptomatic uterine fibroids. The company develops and ablation device for treating uterine fibroids. This healthcare company mission is to design and develop new and advances technologies for improving the  health of women. The company is focused on providing an incision free option for women and the physician who provide healthcare to treat symptomatic uterine fibroids. The company is initiating a pivotal IDE trial in the USA for verifying the safety and efficacy of the Sonata system, in preserving the uterus while treating uterine fibroids that are associated with the abnormal uterine bleeding which are difficult to be treated with the current surgical techniques and existing technology.

How much Gynesonics was funded?

Gynesonics raised $43M in Private Equity round on July 22, 2015 from Endeavour Vision (Lead), Correlation Ventures, Advanced Technology Ventures, Hercules Technology Growth Capital, HBM Partners and InterWest Partners

Previous funding

• $1.5M in Debt Financing on November 17, 2009
• $15.6M in Venture round on May 11, 2010
• $455k in Venture onOctober 28, 2010
• $5M in Debt Financing on February 22, 2012
• $900.2k in Debt Financing on January 24, 2013
• $28.4M in Debt Financing on July 10, 2014 from Abingworth, Correlation Ventures, Advanced Technology Ventures, HBM Partners and InterWest Partners Partner: Doug Fisher
• $3M in Convertible Note round on April 22, 2015 from Correlation Ventures

What is next for Gynesonics?

The company plans to use the latest fund for transforming technologies in digital health and medical devices. The fund will help the company with the capacity in making a significant improvement in women’s lives all over the world who suffer from symptomatic uterine fibroids.

More about Gynesonics

Gynesonics was founded in 2005 by Jessica Grossman. It has its headquarters in Redwood City, CA.